Quidel gets amended clearance for coronavirus antigen tests

By LabPulse.com staff writers

June 11, 2020 -- Quidel has received an amended emergency use authorization from the U.S. Food and Drug Administration to run its rapid antigen diagnostic test for the novel coronavirus on an older immunoassay system.

The amended authorization allows the Sofia SARS Antigen Fluorescent Immunoassay rapid COVID-19 test to run on Quidel's first generation of the Sofia Fluorescent Immunoassay analyzer. The original authorization only cleared the rapid test to run on Quidel's second-generation automated immunoassay instrument.

Both the Sofia 1 and Sofia 2 systems offer distinct workflows and can deliver results within 15 minutes, Quidel noted. When used with the rapid coronavirus antigen test, the system detects fragments of proteins found on or within SARS-CoV-2 in nasal or nasopharyngeal specimens.

Quidel nets EUA, CE Mark for Lyra Direct SARS-CoV-2 assay
Quidel has received emergency use authorization (EUA) from the U.S. Food and Drug Administration (FDA) and the CE Mark for its Lyra Direct SARS-CoV-2...
Quidel clearance signals arrival of rapid antigen tests for coronavirus
Clearance of Quidel's rapid antigen diagnostic test by the U.S. Food and Drug Administration marks the arrival of a third type of assay for the novel...
States ready to conduct more than 12.9M coronavirus tests in May
U.S. states will have the tests and lab supplies they need to conduct a total of more than 12.9 million coronavirus tests in May, covering more than...
Molecular testing and COVID-19: Where are we now?
As the COVID-19 pandemic accelerates, attention has been focused on how to effectively scale up the diagnostic testing that is needed to correctly manage...
Quidel coronavirus test granted emergency authorization
Quidel has received emergency use authorization from the U.S. Food and Drug Administration to market its Lyra SARS-CoV-2 assay, a real-time reverse transcription...

Copyright © 2020 LabPulse.com

Last Updated ls 6/11/2020 4:12:55 PM



Register below for our weekly Letter from the Editor to receive the latest Clinical Lab news and insights.
Email
Subscribe Today
Do you want to be a Microbiology Insider?

When LabPulse gets hot new information, our Insiders are the first to find out. Stay current in today's competitive market by receiving our exclusive free email updates.

Yes, Keep Me Current